Canaccord Genuity Group Issues Pessimistic Forecast for Tenaya Therapeutics (NASDAQ:TNYA) Stock Price
Tenaya Therapeutics (NASDAQ:TNYA – Free Report) had its price target reduced by Canaccord Genuity Group from $18.00 to $6.00 in a research report released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. A number of other analysts have also issued reports on the stock. HC Wainwright dropped their […]
Tenaya Therapeutics (NASDAQ:TNYA – Free Report) had its price target reduced by Canaccord Genuity Group from $18.00 to $6.00 in a research report released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. A number of other analysts have also issued reports on the stock. HC Wainwright dropped their […]
